Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit

J.A.A.C. Heuberger, J.M.C. Tervaert, F.M.L. Schepers, A.D.B. Vliegenthart, J.I. Rotmans, J.M.A. Daniels, J. Burggraaf, A.F. Cohen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1406-1421
JournalBritish Journal of Clinical Pharmacology
Volume75
Issue number6
DOIs
Publication statusPublished - 2013

Cite this

Heuberger, J. A. A. C., Tervaert, J. M. C., Schepers, F. M. L., Vliegenthart, A. D. B., Rotmans, J. I., Daniels, J. M. A., ... Cohen, A. F. (2013). Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit. British Journal of Clinical Pharmacology, 75(6), 1406-1421. https://doi.org/10.1111/bcp.12034
Heuberger, J.A.A.C. ; Tervaert, J.M.C. ; Schepers, F.M.L. ; Vliegenthart, A.D.B. ; Rotmans, J.I. ; Daniels, J.M.A. ; Burggraaf, J. ; Cohen, A.F. / Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit. In: British Journal of Clinical Pharmacology. 2013 ; Vol. 75, No. 6. pp. 1406-1421.
@article{47d212ad72f1481c9dce3f4d3f3ae3f2,
title = "Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit",
author = "J.A.A.C. Heuberger and J.M.C. Tervaert and F.M.L. Schepers and A.D.B. Vliegenthart and J.I. Rotmans and J.M.A. Daniels and J. Burggraaf and A.F. Cohen",
year = "2013",
doi = "10.1111/bcp.12034",
language = "Undefined/Unknown",
volume = "75",
pages = "1406--1421",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "6",

}

Heuberger, JAAC, Tervaert, JMC, Schepers, FML, Vliegenthart, ADB, Rotmans, JI, Daniels, JMA, Burggraaf, J & Cohen, AF 2013, 'Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit' British Journal of Clinical Pharmacology, vol. 75, no. 6, pp. 1406-1421. https://doi.org/10.1111/bcp.12034

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit. / Heuberger, J.A.A.C.; Tervaert, J.M.C.; Schepers, F.M.L.; Vliegenthart, A.D.B.; Rotmans, J.I.; Daniels, J.M.A.; Burggraaf, J.; Cohen, A.F.

In: British Journal of Clinical Pharmacology, Vol. 75, No. 6, 2013, p. 1406-1421.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit

AU - Heuberger, J.A.A.C.

AU - Tervaert, J.M.C.

AU - Schepers, F.M.L.

AU - Vliegenthart, A.D.B.

AU - Rotmans, J.I.

AU - Daniels, J.M.A.

AU - Burggraaf, J.

AU - Cohen, A.F.

PY - 2013

Y1 - 2013

U2 - 10.1111/bcp.12034

DO - 10.1111/bcp.12034

M3 - Article

VL - 75

SP - 1406

EP - 1421

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 6

ER -